A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage

van Rhijn, 2009, Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy, Eur Urol, 56, 430, 10.1016/j.eururo.2009.06.028 2002, 199 Kirkali, 2005, Bladder cancer: epidemiology, staging and grading, and diagnosis, Urology, 66, 4, 10.1016/j.urology.2005.07.062 Nieder, 2005, Management of stage T1 tumors of the bladder: International Consensus Panel, Urology, 66, 108, 10.1016/j.urology.2005.08.066 Stein, 2008, Invasive T1 bladder cancer: indications and rationale for radical cystectomy, BJU Int, 102, 270, 10.1111/j.1464-410X.2008.07743.x Sylvester, 2002, Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials, J Urol, 168, 1964, 10.1016/S0022-5347(05)64273-5 Babjuk, 2011, EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder, the 2011 update, Eur Urol, 59, 997, 10.1016/j.eururo.2011.03.017 Herr, 2008, Is maintenance bacillus Calmette-Guérin really necessary?, Eur Urol, 54, 971, 10.1016/j.eururo.2008.06.062 Griffiths, 2002, Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance, J Urol, 167, 2408, 10.1016/S0022-5347(05)64994-4 Younes, 1990, The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder, Cancer, 66, 543, 10.1002/1097-0142(19900801)66:3<543::AID-CNCR2820660323>3.0.CO;2-R Hasui, 1994, Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer, Urology, 43, 782, 10.1016/0090-4295(94)90134-1 Angulo, 1995, Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer, Urology, 45, 47, 10.1016/S0090-4295(95)96490-8 Platz, 1996, Is microstaging of early invasive cancer of the urinary bladder possible or useful?, Mod Pathol, 9, 1035 Holmang, 1997, The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study, J Urol, 157, 800, 10.1016/S0022-5347(01)65044-4 Smits, 1998, Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression, Urology, 52, 1009, 10.1016/S0090-4295(98)00374-4 Hermann, 1998, The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer, J Urol, 159, 91, 10.1016/S0022-5347(01)64021-7 Kondylis, 2000, Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma, J Urol, 163, 1120, 10.1016/S0022-5347(05)67706-3 Shariat, 2000, Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder, Urology, 56, 735, 10.1016/S0090-4295(00)00756-1 Bernardini, 2001, The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma, J Urol, 165, 42, 10.1097/00005392-200101000-00011 Orsola, 2005, Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients, Eur Urol, 48, 231, 10.1016/j.eururo.2005.04.013 Andius, 2007, Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion, Urology, 70, 758, 10.1016/j.urology.2007.06.638 Mhawech-Fauceglia, 2007, Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis, BJU Int, 100, 1182 Faivre d’Arcier, 2010, T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU), Prog Urol, 20, 440, 10.1016/j.purol.2010.02.002 Eble, 2004 van Rhijn, 2010, Pathological stage review is indicated in primary pT1 bladder cancer, BJU Int, 106, 206, 10.1111/j.1464-410X.2009.09100.x van der Aa, 2005, A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation, Hum Pathol, 36, 981, 10.1016/j.humpath.2005.06.017 Cheng, 1999, Predicting cancer progression in patient with T1 bladder carcinoma, J Clin Oncol, 17, 3182, 10.1200/JCO.1999.17.10.3182 Orsola, 2010, Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR, BJU Int, 105, 202, 10.1111/j.1464-410X.2009.08694.x Sylvester, 2006, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials, Eur Urol, 49, 466, 10.1016/j.eururo.2005.12.031 Denzinger, 2008, Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?, Eur Urol, 53, 146, 10.1016/j.eururo.2007.06.030 Mungan, 2000, Gender differences in stage-adjusted bladder cancer survival, Urology, 55, 876, 10.1016/S0090-4295(00)00523-9 Horstmann, 2008, Gender-specific differences in bladder cancer: a retrospective analysis, Gend Med, 5, 385, 10.1016/j.genm.2008.11.002 Saint, 2002, Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer, J Urol, 167, 364, 10.1016/S0022-5347(05)65469-9 Herr, 2007, Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?, J Urol, 177, 75, 10.1016/j.juro.2006.08.070 Divrik, 2010, Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial, Eur Urol, 58, 185, 10.1016/j.eururo.2010.03.007